Aggregate hedge fund holdings in Bristol Myers Squibb (BMY) significantly increased during the second quarter of 2025, with institutional investors adding 4,677,682 shares for a 5.90% rise, bringing total reported long positions to 83,927,343 shares by June 30, 2025. This notable increase in aggregate long positions, as revealed by the latest 13F filings, suggests a growing institutional conviction in BMY, warranting further research despite the inherent limitations of 13F data.
Analysis of 13F filings for the period ending June 30, 2025, reveals a significant increase in aggregate institutional ownership of Bristol Myers Squibb Co. (BMY). Across all reporting funds surveyed, holdings rose by 4,677,682 shares, a 5.90% increase, bringing the total reported long positions to 83,927,343 shares. This broad accumulation suggests growing institutional conviction in the stock. A closer look at a recent sample of ten funds presents a more mixed, though ultimately positive, picture in terms of share count. While five funds in this smaller cohort reduced their positions, these were more than offset by two funds increasing their stakes and one substantial new position initiated by TrueMark Investments LLC for 105,903 shares. The aggregate market value change for this small sample was negative (-$8.1 million) despite a net increase in shares (+110,478), which could imply share price weakness during the quarter that may have been viewed as a buying opportunity. It is crucial to note the inherent limitation of 13F data, as it only reflects long positions and does not capture bearish bets or complex derivatives strategies, meaning the reported holdings may not represent a fund's full net exposure.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
